Cellbyte, a Munich-based AI-native platform helping pharmaceutical companies accelerate drug launches, has raised $2.75 ...
GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance (AMR), backed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback